Please login to the form below

Not currently logged in

Galectin Therapuetics appoints Harold Shlevin as chief operating officer

Will replace company co-founder Maureen Foley

Harold ShlevinDr Harold Shlevin has been appointed chief operating officer of Galectin Therapeutics, a US-based company that develops therapeutics that target galectin proteins to treat fibrosis and cancer.

Dr Shlevin (pictured) will take over from company co-founder Maureen Foley on October 1, 2012, as Galectin looks to advance its drug candidates.

Peter Traber, president, CEO and chief marketing offcier of Galectin said: “Dr Shlevin will be a tremendous asset to Galectin Therapeutics as he brings a broad range of technical, managerial and leadership experience in small, medium and large pharmaceutical companies that includes a track-record of attracting capital, competing successfully to negotiate partnering deals and developing and commercialising new pharmaceutical products.”

Most recently, Dr Shlevin led Georgia Institute of Technology's Advanced Technology Development Center (ATDC) as principle and manager of bioscience commercialisation efforts, where he helped the development of new bioscience startup companes.

Previously, he served as president and CEO of Solvay Pharmaceuticals, where he oversaw the successful launch of the first topical testosterone gel product in the US and he was co-founder of CIBA Vision Ophthalmics, a specialty ophthalmic drug company.

He also founded, and was president and CEO of, Tikvah Therapeutics, a company focused on clinical development of therapeutics for treatment of neurological diseases, and was once also VP and head of operations and commercial development for Altea Therapeutics Corporation.

31st August 2012


Featured jobs

Subscribe to our email news alerts


Add my company

WCG is an independent, global agency specialising in healthcare communications. Our value as a company is about being the positive...

Latest intelligence

Waking the sleeping giant
The lights are coming on for healthcare delivery in Africa...
How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...